2020
DOI: 10.1111/head.13755
|View full text |Cite
|
Sign up to set email alerts
|

Cranial and Facial Epicrania Fugax: Combination of Both Clinical Pictures in the Same Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 8 publications
1
5
0
Order By: Relevance
“…These patients presented with paroxysms of pain that crossed several dermatomes of the face, either upwards or downwards (Figure 7), with or without extension into the cranial region (120,121). Moreover, two additional cases have been reported that combined episodes of facial and cranial EF (122); this finding supports the idea that both types of EF are just two distinct clinical presentations of the same disease.…”
Section: Epicrania Fugaxsupporting
confidence: 64%
See 1 more Smart Citation
“…These patients presented with paroxysms of pain that crossed several dermatomes of the face, either upwards or downwards (Figure 7), with or without extension into the cranial region (120,121). Moreover, two additional cases have been reported that combined episodes of facial and cranial EF (122); this finding supports the idea that both types of EF are just two distinct clinical presentations of the same disease.…”
Section: Epicrania Fugaxsupporting
confidence: 64%
“…The drugs most used in EF are antiseizure medications; satisfactory therapeutic responses have been reported for several drugs in this group, especially gabapentin (30,(71)(72)(73)(74)109,116,(120)(121)(122)124) and lamotrigine (71)(72)(73)(74)(75)116,120,121,124) but also pregabalin (74,121), carbamazepine (73,103,117,121), oxcarbazepine (120,121), eslicarbazepine (107,121,125), lacosamide (121), and levetiracetam (74). Amitriptyline (73,75,116,122), duloxetine (120), and indomethacin (74,75) have also been used with effect in a minority of patients. If the response to initial treatment is unsatisfactory, another treatment may be tried, as patients who do not respond to the first option may find relief with subsequent options.…”
Section: Treatmentmentioning
confidence: 99%
“…Among these atypical cases, one had a sagittal trajectory (7), four had coronal trajectories (8), and one had paroxysms running in multiple directions (9). A facial variant of EF has also been described in 15 patients, with the pain crossing several dermatomes of the face in an upward or downward direction (10)(11)(12)). Yet, until very recently, all the described cases were circumscribed to trigeminal or occipital nerve territories.…”
Section: Introductionmentioning
confidence: 99%
“…6 The hypothesis of a possible central generator would be further reinforced by the existence of EF cases in which pain can originate at different points and travel along different trajectories. [8][9][10][11][12] EF is probably not a purely "peripheral" or purely "central" disorder. The genesis of pain could rely on peripheral generators (epicranial or intracranial) or, alternatively, on CNS generators.…”
mentioning
confidence: 99%